| Variable |
Crude Analysis |
Adjusted Analysis* |
| Odds Ratio (95% CI) |
P value |
Odds Ratio (95% CI) |
P value |
| Age in years |
1.0 (0.95-1.04) |
0.8 |
- |
- |
| Race/Ethnicity |
| Non-hispanic white |
Reference |
- |
- |
- |
| Non-hispanic black |
1.52 (0.47-4.9) |
- |
- |
- |
| Other |
1.33 (0.18-9.73) |
0.78 |
- |
- |
| Weight in Kg |
0.99 (0.97-1.01) |
0.33 |
0.99 (0.96-1.01) |
0.24 |
| Gender |
| Male |
Reference |
- |
- |
- |
| Female |
0.5 (0.15-1.66) |
0.26 |
- |
- |
| TDF stopped |
| No |
Reference |
- |
- |
- |
| Yes |
2.54 (0.97-6.64) |
0.06 |
3.76 (1.26-11.27) |
0.02 |
| Increase in sCr ≥0.3 mg/dl |
1.00 (0.87-1.15) |
0.97 |
0.75 (0.45-1.23) |
0.25 |
| Baseline CKD1 |
| No |
Reference |
- |
- |
- |
| Yes |
0.16 (0.04-0.68) |
0.01 |
- |
|
| HCV Antibody |
| Negative |
Reference |
- |
- |
- |
| Positive |
2.32 (0.69-7.81) |
0.18 |
- |
- |
| Diabetes Mellitus |
| No |
Reference |
|
Reference |
|
| Yes |
0.63 (0.18-2.2) |
0.46 |
0.29 (0.06-1.48) |
0.14 |
| Hypertension |
| No |
Reference |
|
Reference |
|
| Yes |
1.09 (0.42-2.81) |
0.86 |
1.59 (0.45-5.66) |
0.47 |
| Nephrotoxic drugs |
| No |
Reference |
|
Reference |
|
| Yes |
1.16 (0.46–2.96) |
0.76 |
1.34 (0.43-4.21) |
0.61 |
| HIV-1 PVL2 |
| ≤75 log10 copies/ml |
Reference |
|
|
|
| >75 log10 copies/ml |
0.52 (0.18-1.54) |
0.24 |
|
|
| CD4 cell count2 |
| ≤200 cells/µL |
Reference |
|
|
|
| >200 cells/µL |
0.86 (0.33-2.21) |
0.75 |
|
|
|